Search tool

Displaying 891 - 900 of 4575

Alexis Goosdeel, EMCDDA Director

Impact of COVID-19 on the drug situation in Europe — EMCDDA Director presents findings to European Parliament

Today, EMCDDA Director Alexis Goosdeel presented to the European Parliament the agency’s recent research findings on the impact of COVID-19 on the drug phenomenon in Europe. Speaking via video conference to the...

Presentation of the EMCDDA Director to the LIBE Committee of the European Parliament

The EMCDDA Director, Mr Alexis Goosdeel, will make a presentation to the LIBE Committee of the European Parliament on the The impact of the COVID-19 pandemic on the drugs situation in Europe.

Publication thumbnail

EMCDDA technical report on the new psychoactive substance N,Ndiethyl- 2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1Hbenzimidazole- 1-ethanamine (isotonitazene)

The purpose of this technical report is to provide an analysis of the available information on N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1-ethanamine (commonly known as isotonitazene), an opioid analgesic that has recently emerged on the drug market...

Document library

COVID-19 and addiction issues

Home page for COVID and addiction services, established by the German Drug Coordinator, providing links to relevant guidance and legislation to ensure continuity of services.

Document library

COVID-19 and people who use drugs - The Pompidou Group’s Response Platform

The Pompidou Group’s Response Platform - Let’s work together to contain the spread of COVID-19 and prevent harm to people who use drugs and those in contact with them. The platform Save...

Document library

COVID-19 In Vitro Diagnostic Devices and Test Methods Database

EU database of COVID-19 in vitro diagnostic devices and test methods that gathers information on available tests in one place, providing guidance on the use of coronavirus tests.

Publication cover

Document library

Document library: COPOLAD early warning systems (EWS) on NPS and emerging drug phenomena

This manual was developed with the goal of promoting and facilitating the establishment of Early Warning Systems (EWSs) and agreements for information exchange between National Drug Councils, National Drug Observatories and other...

Document library

Maintaining essential health services: operational guidance for the COVID-19 context

Supports country implementation of targeted actions at the national, subnational and local levels to reorganize and maintain access to safe and high-quality essential health services.

EU Drug Markets — Impact of COVID-19

What effect is COVID-19 having on the drug market in the EU? This joint publication from the EMCDDA and Europol analyses the impact of the pandemic on the market for the main...

Changes in drug price and availability

Infographic: Changes in drug price and availability